Glucose
Sensor Market, by Product Type (Non-invasive (Optical Sensors and
Transdermal Sensors), Invasive (Intravenous Implantable, Micro Dialysis, and
Subcutaneous Sensor), and Minimally Invasive (Micro Pore/ Micro Needles)), by
Technology (Polarimetry, Raman Spectroscopy, (Near) Infrared Spectroscopy, MIR
Spectroscopy, Impedance Spectroscopy, Fluorescence, Photo-Acoustic
Spectroscopy, Optical Coherence Tomography, Skin Suction Blister Technique,
Sonophoresis, and Reverse Iontophoresis), by Distribution Channel (Hospitals,
Clinics, Home Care Settings, and Others), and by Region (North America, Europe,
Asia Pacific, Latin America, Middle East, and Africa) - Size, Share, Outlook,
and Opportunity Analysis, 2018 – 2026
Glucose sensors are inserted
under skin to measure glucose (sugar) levels. These sensors are connected
wirelessly to the continuous glucose monitoring system. They offer data to the
monitoring system or smart compatible devices that aid to track the level of
blood glucose in a patient at regular intervals.
Global Glucose Sensor Market:
Drivers
Increasing number of pipeline
studies to develop new glucose sensors is expected to boost the glucose sensor
market growth. For instance, in April 2018, University of California San Diego,
in collaboration with National Institutes of Health (NIH), initiated the
clinical study for adhesive glucose sensor to measure sweat glucose of patients
with diabetes. The main aim of this clinical study is to explore the accuracy
and acceptability of a non-invasive, wearable glucose sensor in patients living
with Diabetes Mellitus. The study is estimated to be completed by June 2019.
* The sample copy includes:
Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report
Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/2490
Moreover, new product launches
for measuring blood glucose levels is also expected to contribute to growth of
the glucose sensor market size. For instance, in December 2018, Nemaura Medical
Inc., a medical technology company developing sugarBEAT, signed licensing and
distribution agreement with Doha-based Al-Danah Medical Co. to commercially
launch sugarBEAT in Qatar by 2019. sugarBEAT is the first painless,
non-invasive continuous glucose monitor (CGM) for use by diabetic and
pre-diabetic patients.
Global Glucose Sensor Market:
Regional Analysis
On the basis of region, the
global glucose sensor market is segmented into North America, Latin America,
Europe, Asia Pacific, Middle East, and Africa.
North America is expected to
witness significant growth in the glucose sensor market, owing to presence of
major players and launch of new products in this region. For instance, in July
2018, Abbott Laboratories received the U.S. Food and Drug Administration (FDA)
approval for its FreeStyle Libre 14 day Flash Glucose Monitoring System. The
system allows a diabetic patient to wear
the sensor up to 14 days and offers results with high accuracy. It is the first
continuous glucose monitoring system that can be used by diabetic patients to
take diabetes treatment decisions without using a blood sample from the
fingertip.
Browse Research
Report: https://www.coherentmarketinsights.com/ongoing-insight/glucose-sensor-market-2490
The systems eliminates the need
for fingerstick testing by using a small sensor wire inserted below the skin’s
surface. This sensor continuously measures and monitors glucose levels.
Furthermore, Asia Pacific glucose
sensor market is expected to witness significant growth over the forecast
period, owing to increasing diabetes healthcare spending in the region. For
instance, according to the International Diabetes Federation’ (IDF) estimates,
in 2017, diabetic healthcare spending in Asia Pacific was US$ 241 million.
Key players operating in the
global glucose sensor market include, Abbott Diagnostics, Pinnacle
Technologies, Inc., 77 Elektronika KFT, Sanofi-Deutschland GmbH, Life Scan
(Johnson and Johnson Company), Universal Biosensors, Diamontech GmbH, Medical
Wireless Sensing Ltd, Medtronic MiniMed, Inc. Bayer Healthcare, DexCom Inc.,
Nova Biomedical Corporation, Terumo Europe NV, Arkay, Inc., and Roche
Diagnostics.
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/2490
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar
opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
No comments:
Post a Comment